$4.22
+0.04(0.96%)
Mkt Cap $27M
$3.51
$12.80
52-Week Range
At a Glance
AI-generatedExicure, Inc.
Revenue breakdown: Biotechnology Segment (100%).
8-K
Exicure, Inc. announced the preliminary court approval of a settlement to resolve stockholder derivative litigation alleging fiduciary breaches related to internal controls and statements about drug candidate XCUR-FXN, requiring corporate governance reforms and a $675,000 fee payment.$27M
Market Cap
—
Revenue
-$9M
Net Income
Employees7
Fundamentals
How The Business Makes Money
Revenue by Segment
Biotechnology Segment100%($500.0K)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001698530
ISINUS30205M3097
CUSIP30205M101
Phone847 673 1700
Address2430 North Halsted Street, Chicago, IL, 60614, US
SEC EDGAR